<!--HTML document created with Certent Disclosure Management 6.5.8.2-->
<!--Created on: 3/23/2017 11:21:32 AM-->
<html>
	<head>
		<title>
			S-8 2017-03-22
		</title>
	</head>
	<body><div style="margin-left:36pt;margin-right:36pt;">
		<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;font-size: 1pt">
			<a name="_GoBack"></a><font style="display: inline;font-size:1pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width:544.50pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:180.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="3" valign="top" style="width:193.45pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:170.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 3.6pt 2.5pt 0pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">As filed with the Securities and Exchange Commission on March 2</font><font style="display: inline;font-weight:bold;font-size:8pt;">3</font><font style="display: inline;font-weight:bold;font-size:8pt;">, 2017</font></p>
					<p style="margin:0pt 31.75pt 2.5pt 0pt;line-height:95%;text-align:right;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Registration No. 333-</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:3.5pt 0pt 0pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 16pt">
						<font style="display: inline;font-weight:bold;font-size:16pt;">UNITED STATES</font></p>
					<p style="margin:3.5pt 0pt 0pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 16pt">
						<font style="display: inline;font-weight:bold;font-size:16pt;">SECURITIES AND EXCHANGE COMMISSION</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Washington, D.C. 20549</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;height:10.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 15pt">
						<font style="display: inline;font-weight:bold;font-size:15pt;">FORM S-8</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 13pt">
						<font style="display: inline;font-weight:bold;font-size:13pt;">REGISTRATION STATEMENT</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-style:italic;font-size:9pt;">UNDER </font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-style:italic;font-size:9pt;">THE SECURITIES ACT OF 1933</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;height:10.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 20pt">
						<font style="display: inline;font-weight:bold;font-size:20pt;">Pulse Biosciences, Inc.</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:6pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 7pt">
						<font style="display: inline;font-weight:bold;font-size:7.5pt;">(Exact name of Registrant as specified in its charter)</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;height:10.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:180.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">&#xFEFF;</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Nevada </font></p>
				</td>
				<td colspan="3" valign="top" style="width:193.45pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:170.75pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">46-5696597</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:180.30pt;padding:0pt;">
					<p style="margin:6pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 7pt">
						<font style="display: inline;font-weight:bold;font-size:7pt;">(State or other jurisdiction of</font><br /><font style="display: inline;font-weight:bold;font-size:7pt;">incorporation or organization)</font></p>
				</td>
				<td colspan="3" valign="top" style="width:193.45pt;padding:0pt;">
					<p style="margin:6pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="top" style="width:170.75pt;padding:0pt;">
					<p style="margin:6pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 7pt">
						<font style="display: inline;font-weight:bold;font-size:7pt;">(I.R.S. Employer</font><br /><font style="display: inline;font-weight:bold;font-size:7pt;">Identification No.)</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="bottom" style="width:544.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">849 Mitten Road, Suite 104</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Burlingame, CA 94010</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:6pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 7pt">
						<font style="display: inline;font-weight:bold;font-size:7pt;">(Address of principal executive offices, including zip code)</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;height:10.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-size:12pt;">2015 Stock Incentive Plan</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-size:12pt;">Pulse Biosciences, Inc. Stock Option Agreement dated February 1, 2015 </font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-size:12pt;">between Pulse Biosciences, Inc. and Robert M. Levande</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-size:12pt;">Pulse Biosciences, Inc. Stock Option Agreement dated February 1, 2015 </font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-size:12pt;">between Pulse Biosciences, Inc. and Mitchell E. Levinson</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-size:12pt;">Pulse Biosciences, Inc. Stock Option Agreement dated June 1, 2015 </font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-size:12pt;">between Pulse Biosciences, Inc. and Robert J. Greenberg</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-size:12pt;">Pulse Biosciences, Inc. Stock Option Agreement dated June 16, 2015 </font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;font-size:12pt;">between Pulse Biosciences, Inc. and Thierry Thaure</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:6pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 7pt">
						<font style="display: inline;font-weight:bold;font-size:7pt;">(Full title of the plan)</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;height:10.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Darrin R. Uecker</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Chief Executive Officer</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Pulse Biosciences, Inc. </font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">849 Mitten Road, Suite 104</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Burlingame, CA 94010</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">(650) 697-3939</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:6pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 7pt">
						<font style="display: inline;font-weight:bold;font-size:7pt;">(Name, address and telephone number, including area code, of agent for service) </font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;height:10.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:180.30pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<br /><font style="display: inline;font-weight:bold;font-size:9pt;">Andrew D. Hoffman</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C.</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">650 Page Mill Road</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Palo Alto, California 94304</font></p>
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">(650) 493-9300</font></p>
				</td>
				<td colspan="3" valign="top" style="width:193.45pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-style:italic;font-size:9pt;">Copies to:</font></p>
				</td>
				<td colspan="2" valign="top" style="width:170.75pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Brian B. Dow</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Chief Financial Officer</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Pulse Biosciences, Inc. </font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">849 Mitten Road, Suite 104</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">Burlingame, CA 94010</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">(650) 697-3939</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="top" style="width:270.25pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="4" valign="top" style="width:274.25pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;height:10.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.&nbsp;&nbsp;See the definitions of &#x201C;large accelerated filer,&#x201D; &#x201C;accelerated filer&#x201D; and &#x201C;smaller reporting company&#x201D; in Rule&nbsp;12b-2 of the Exchange Act (Check one).</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="top" style="width:301.45pt;padding:0pt;">
					<p style="margin:3pt 0pt 0pt 36.25pt;line-height:100%;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Large accelerated filer</font><a name="Check1"></a><font style="display: inline;font-size:8pt;">&nbsp;&nbsp;&nbsp;</font><font style="display: inline;font-weight:bold;font-size:8pt;">&#x2610;</font></p>
					<p style="margin:3pt 0pt 0pt 36.25pt;line-height:100%;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Non-accelerated filer</font><font style="display: inline;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="display: inline;font-weight:bold;font-size:8pt;">&#x2610;</font><font style="display: inline;font-size:8pt;"> (Do not check if a smaller reporting company)</font></p>
				</td>
				<td colspan="2" valign="top" style="width:121.50pt;padding:0pt;">
					<p style="margin:3pt 0pt 0pt;line-height:100%;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Accelerated filer</font></p>
					<p style="margin:3pt 0pt 0pt;line-height:100%;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Smaller reporting company</font></p>
				</td>
				<td valign="top" style="width:121.55pt;padding:0pt;">
					<p style="margin:3pt 0pt 0pt;line-height:100%;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">&#x2610;</font><font style="display: inline;">&nbsp;</font></p>
					<p style="margin:3pt 0pt 0pt;line-height:100%;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">&#x2612;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="6" valign="top" style="width:544.50pt;height:10.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 1pt">
			<font style="display: inline;font-size:1pt;">&#xFEFF;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 1pt">
			<font style="display: inline;font-size:1pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width:544.75pt;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;height:1.00pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td colspan="5" valign="top" style="width:544.75pt;padding:0pt;">
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">&#xFEFF;</font></p>
					<p style="margin:12pt 0pt 0pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;">CALCULATION OF REGISTRATION FEE</font></p>
					<p style="margin:0pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1.5pt 0pt 1pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Title of Securities to be Registered</font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:2pt double #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1.5pt 0pt 1pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Amount</font><br /><font style="display: inline;font-weight:bold;font-size:8pt;">to be Registered (1)</font></p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:2pt double #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1.5pt 0pt 1pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Proposed</font><br /><font style="display: inline;font-weight:bold;font-size:8pt;">Maximum Offering</font><br /><font style="display: inline;font-weight:bold;font-size:8pt;">Price Per Share </font></p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:2pt double #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1.5pt 0pt 1pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Proposed</font><br /><font style="display: inline;font-weight:bold;font-size:8pt;">Maximum Aggregate Offering Price</font></p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:2pt double #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1.5pt 0pt 1pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Amount of</font><br /><font style="display: inline;font-weight:bold;font-size:8pt;">Registration Fee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt 13.7pt;line-height:95%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">Common Stock, $0.001 par value per share: </font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt 13.7pt;line-height:95%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">&#x2014;Reserved for issuance under the 2015 Stock Incentive Plan</font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">208,248 (2)</font></p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$23.57 (4)</font></p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$4,908,405.36</font></p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$568.89</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt 13.7pt;line-height:95%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">&#x2014;Reserved for issuance pursuant to </font><font style="display: inline;color:#000000;font-size:8pt;">equity awards outstanding under the 2015 Stock Incentive Plan</font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">922,970 (3)</font></p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$4.19 (5)</font></p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$3,867,244.30</font></p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$448.22</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt 13.7pt;line-height:95%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">&#x2014;Reserved for issuance pursuant to </font><font style="display: inline;color:#000000;font-size:8pt;">the Pulse Biosciences, Inc. Stock Option Agreement dated February 1, 2015 between Pulse Biosciences, Inc. and Robert M. Levande</font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">75,655</font></p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$2.67 (6)</font></p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$201,998.85</font></p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$23.42</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt 13.7pt;line-height:95%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">&#x2014;Reserved for issuance pursuant to </font><font style="display: inline;color:#000000;font-size:8pt;">the Pulse Biosciences, Inc. Stock Option Agreement dated February 1, 2015 between Pulse Biosciences, Inc. and Mitchell E. Levinson</font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">75,655</font></p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$2.67 (6)</font></p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$201,998.85</font></p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$23.42</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt 13.7pt;line-height:95%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">&#x2014;Reserved for issuance pursuant to </font><font style="display: inline;color:#000000;font-size:8pt;">the Pulse Biosciences, Inc. Stock Option Agreement dated June 1, 2015 between Pulse Biosciences, Inc. and Robert J. Greenberg</font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">75,655</font></p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$2.67 (6)</font></p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$201,998.85</font></p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$23.42</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt 13.7pt;line-height:95%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">&#x2014;Reserved for issuance pursuant to </font><font style="display: inline;color:#000000;font-size:8pt;">the Pulse Biosciences, Inc. Stock Option Agreement dated June 16, 2015 between Pulse Biosciences, Inc. and Thierry Thaure</font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">75,655</font></p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$2.67 (6)</font></p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$201,998.85</font></p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$23.42</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:202.25pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:1pt 0pt 1.5pt 13.7pt;line-height:95%;text-align:center;font-family:Times New Roman;font-size: 8pt">
						<font style="display: inline;font-weight:bold;font-size:8pt;">Total:</font></p>
				</td>
				<td valign="bottom" style="width:81.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">1,433,838</font></p>
				</td>
				<td valign="bottom" style="width:90.05pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:81.75pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt solid #000000 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$9,583,645.06</font></p>
				</td>
				<td valign="bottom" style="width:89.65pt;border-top:1pt solid #000000 ;border-left:1pt solid #000000 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 5.2pt 0pt 5.2pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 8pt">
						<font style="display: inline;font-size:8pt;">$1,110.79</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:95%;font-family:Times New Roman;font-size: 1pt">
			<font style="display: inline;font-size:1pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:25pt;"><p style="width:25pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:12pt 0pt 0pt;">
				<font style="margin:12pt 0pt 0pt;font-size:9pt;line-height:100%;font-family:Times New Roman;;"> (1)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:12pt 0pt 0pt;">
			<font style="display: inline;color:#000000;font-size:9pt;">Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of common stock of the Registrant that become issuable under the 2015 Stock Incentive Plan (the &#x201C;2015 Plan&#x201D;) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant&#x2019;s outstanding shares of common stock.&nbsp; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:25pt;"><p style="width:25pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
				<font style="margin:0pt;font-size:9pt;line-height:100%;font-family:Times New Roman;;"> (2)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
			<font style="display: inline;color:#000000;font-size:9pt;">Represents </font><font style="display: inline;color:#000000;font-size:9pt;">208,248</font><font style="display: inline;color:#000000;font-size:9pt;"> shares of common stock reserved for issuance pursuant to future awards under the 2015 Plan as of the date of the Registration Statement.</font><font style="display: inline;color:#000000;font-size:9pt;"> &nbsp; &nbsp;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:25pt;"><p style="width:25pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
				<font style="margin:0pt;font-size:9pt;line-height:100%;font-family:Times New Roman;;"> (3)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
			<font style="display: inline;font-size:9pt;color:#000000;">Represents 922,970 shares of common stock subject to outstanding awards previously granted under the </font><font style="display: inline;color:#000000;font-size:9pt;">2015 Plan </font><font style="display: inline;font-size:9pt;color:#000000;">as of the date of this Registration Statement.</font><font style="display: inline;font-size:9pt;color:#000000;"> &nbsp; &nbsp;</font><a name="P264968078"></a></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:25pt;"><p style="width:25pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
				<font style="margin:0pt;font-size:9pt;line-height:100%;font-family:Times New Roman;;"> (4)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
			<font style="display: inline;font-size:9pt;color:#000000;">Estimated solely for the purposes of determining the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act of 1933, as amended, on the basis of $23.57, which represents the average of the high and low prices of the Registrant&#x2019;s Common Stock, as reported on the </font><font style="display: inline;font-size:9pt;color:#000000;">Nasdaq</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-size:9pt;color:#000000;">Capital Market on March 20, 2017.</font><font style="display: inline;">&nbsp;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:25pt;"><p style="width:25pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
				<font style="margin:0pt;font-size:9pt;line-height:100%;font-family:Times New Roman;;"> (5)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
			<font style="display: inline;font-size:9pt;color:#000000;">Estimated solely for the purposes of determining the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act of 1933, as amended, on the basis of $</font><font style="display: inline;font-size:9pt;color:#000000;">4.19</font><font style="display: inline;font-size:9pt;color:#000000;">, the weighted-average exercise price for outstanding option awards granted under the 2015 Plan as of the date of the Registration Statement.</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:25pt;"><p style="width:25pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
				<font style="margin:0pt;font-size:9pt;line-height:100%;font-family:Times New Roman;;"> (6)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;font-family:Times New Roman;font-size: 9pt;margin:0pt;">
			<font style="display: inline;font-size:9pt;color:#000000;">Estimated solely for the purposes of determining the registration fee pursuant to Rule 457(h) under the Securities Act of 1933, as amended, on the basis of $2.67, the exercise price for outstanding option awards granted under the applicable Stock Option Agreement.</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman;line-height:107.92%;font-size: 11pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman;line-height:107.92%;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:36pt;margin-right:54pt;">
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<a name="OLE_LINK1"></a><a name="OLE_LINK2"></a>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;font-weight:bold;font-size:10pt;">PART I</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">INFORMATION REQUIRED IN THE PROSPECTUS</font><font style="display: inline;font-weight:bold;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">The information specified in Item&nbsp;1 and Item&nbsp;2 of Part&nbsp;I of Form S-8 is omitted from this Registration Statement on Form S-8 (the &#x201C;</font><font style="display: inline;font-weight:bold;font-size:10pt;">Registration Statement</font><font style="display: inline;font-size:10pt;">&#x201D;) in accordance with the provisions of Rule&nbsp;428 under the Securities Act of 1933, as amended (the &#x201C;</font><font style="display: inline;font-weight:bold;font-size:10pt;">Securities Act</font><font style="display: inline;font-size:10pt;">&#x201D;), and the introductory note to Part&nbsp;I of Form S-8.&nbsp;&nbsp;The documents containing the information specified in Part&nbsp;I of Form S-8 will be delivered to the participants of the equity benefit plans and to option award recipients pursuant to stock option agreements covered by this Registration Statement as specified by Rule&nbsp;428(b)(1) under the Securities Act.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">PART II</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">Item 3.&nbsp;&nbsp;Incorporation of Documents by Reference.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Pulse Biosciences, Inc. (the &#x201C;</font><font style="display: inline;font-weight:bold;font-size:10pt;">Registrant</font><font style="display: inline;font-size:10pt;">&#x201D;) hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the &#x201C;</font><font style="display: inline;font-weight:bold;font-size:10pt;">Commission</font><font style="display: inline;font-size:10pt;">&#x201D;):</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:12pt 0pt 0pt;">
				<font style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size:10pt;;"> (1)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:12pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">The Registrant&#x2019;s Annual Report on Form 10-K for its fiscal year ended December 31, 2016, filed with the Commission on March 20, 2017;</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 0pt 36pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:120%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:12pt 0pt 0pt;">
				<font style="margin:12pt 0pt 0pt;line-height:120%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size:10pt;;"> (2)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:120%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:12pt 0pt 0pt;">
			<font style="display: inline;font-family:inherit;font-size:10pt;color:#000000;">All other reports filed by the Registrant with the Commission pursuant to Sections 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Registrant&#x2019;s Annual Report referred to in (1) above; and</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;"><p style="width:36pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:12pt 0pt 0pt;">
				<font style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size:10pt;;"> (3)</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt;margin:12pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">The description of the Registrant&#x2019;s Common Stock contained in the Registrant&#x2019;s Registration Statement on Form 8-A (File No. 001-37744) filed with the Commission on April 15, 2016 </font><font style="display: inline;font-size:10pt;color:#000000;">pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the &#x201C;</font><font style="display: inline;font-weight:bold;font-size:10pt;color:#000000;">Exchange Act</font><font style="display: inline;font-size:10pt;color:#000000;">&#x201D;), including any amendment or report filed for the purpose of updating such description.</font></p></td></tr></table></div>
		<p style="margin:0pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">All documents filed by the Registrant pursuant to Sections&nbsp;13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the respective dates of filing of such documents; </font><font style="display: inline;font-style:italic;font-size:10pt;color:#000000;">provided</font><font style="display: inline;font-size:10pt;color:#000000;">, &nbsp;</font><font style="display: inline;font-style:italic;font-size:10pt;color:#000000;">however</font><font style="display: inline;font-size:10pt;color:#000000;">, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.&nbsp;&nbsp;Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:24.5pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;color:#000000;">Item 4.&nbsp;&nbsp;Description of Securities.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">Not applicable.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;color:#000000;">Item 5.&nbsp;&nbsp;Interests of Named Experts and Counsel.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">Not applicable.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;color:#000000;">Item 6.&nbsp;&nbsp;Indemnification of Directors and Officers.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;background-color: #FFFFFF;">Under Sections 78.7502, 78.751 and 78.752 of the Nevada Revised Statutes, the Registrant has broad powers to indemnify and insure its directors and officers against liabilities they may incur in their capacities as such.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;background-color: #FFFFFF;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">The Registrant&#x2019;s officers and directors are shielded, as provided by the Nevada Revised Statutes and the Registrant&#x2019;s articles of incorporation and bylaws, from liability to the company or the stockholders for monetary liabilities unless it is specifically </font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt;background-color: #FFFFFF;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt"><font style="display: inline;color:#000000;font-size:10pt;">limited by its articles of incorporation.&nbsp;&nbsp;The Registrant&#x2019;s articles of incorporation do not impose any limit on its directors&#x2019; liability.&nbsp;&nbsp;Excepted under the law from that limitation of liability are: (a)&nbsp;a willful failure to deal fairly with the company or its stockholders in connection with a matter in which the director has a material conflict of interest; (b)&nbsp;a violation of criminal law, unless the director had reasonable cause to believe that his or her conduct was lawful or no reasonable cause to believe that his or her conduct was unlawful; (c)&nbsp;a transaction from which the director derived an improper personal profit; and (d)&nbsp;willful misconduct.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;background-color: #FFFFFF;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">The Registrant&#x2019;s articles of incorporation and bylaws provide that it will indemnify its directors and officers to the fullest extent not prohibited by Nevada law; provided, however, that it may modify the extent of such indemnification by individual contracts with its directors and officers; and, provided, further, that it shall not be required to indemnify any director or officer in connection with any proceeding, or part thereof, initiated by such person unless such indemnification: (a)&nbsp;is expressly required to be made by law, (b)&nbsp;the proceeding was authorized by the Registrant&#x2019;s board of directors, (c)&nbsp;is provided by it, in its sole discretion, pursuant to the powers vested in it under Nevada law or (d)&nbsp;is required to be made pursuant to the bylaws.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;background-color: #FFFFFF;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;color:#000000;font-size:10pt;">In addition to the foregoing, the Registrant has entered into individual indemnification agreements with each of its directors, which provide for the indemnification of each of them for any expenses, settlements and other costs associated or incurred with their defense or involvement with an action brought by a stockholder or third party in connection with their activities as a director.&nbsp;&nbsp;The Registrant maintains insurance coverage for the benefit of its current and past directors, officers and employees, including those of its subsidiaries.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:24.5pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">These indemnification provisions and the indemnification agreements entered into between the Registrant and its officers and directors may be sufficiently broad to permit indemnification of the Registrant&#x2019;s officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:24.5pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">See also the undertakings set out in response to Item&nbsp;9 herein. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">Item 7.&nbsp;&nbsp;Exemption from Registration Claimed.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Not applicable.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">Item 8.&nbsp;&nbsp;Exhibits.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">See the Exhibit Index on the page immediately following the signature pages to the Registration Statement.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:bold;font-size:10pt;">Item 9. Undertakings.</font>
		</p>
		<p style="margin:12pt 0pt 0pt 36pt;line-height:100%;text-indent: -36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">A.</font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 30pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The undersigned Registrant hereby undertakes: </font>
		</p>
		<p style="margin:12pt 0pt 0pt 72pt;line-height:100%;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(1)</font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 27pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</font>
		</p>
		<p style="margin:12pt 0pt 0pt 108pt;line-height:100%;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(i)</font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 27pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;</font>
		</p>
		<p style="margin:12pt 0pt 0pt 108pt;line-height:100%;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(ii)</font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 24pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#x201C;Calculation of Registration Fee&#x201D; table in the effective Registration Statement; and</font>
		</p>
		<p style="margin:12pt 0pt 0pt 108pt;line-height:100%;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(iii)</font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 21pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.</font>
		</p>
		<p style="margin:12pt 0pt 0pt 36pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-style:italic;font-size:10pt;">Provided, however</font><font style="display: inline;font-size:10pt;">, that paragraphs (A)(1)(i) and (A)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission </font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt 36pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;font-size:10pt;">by the Registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.</font>
		</p>
		<p style="margin:12pt 0pt 0pt 63.35pt;line-height:100%;text-indent: -27.35pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(2)</font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">That, f</font><font style="display: inline;font-size:10pt;">or the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font>
		</p>
		<p style="margin:12pt 0pt 0pt 63.35pt;line-height:100%;text-indent: -27.35pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">(3)</font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </font>
		</p>
		<p style="margin:12pt 0pt 0pt 36pt;line-height:100%;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">B.</font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 30pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#x2019;s annual report pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#x2019;s annual report pursuant to Section&nbsp;15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </font>
		</p>
		<p style="margin:12pt 0pt 0pt 36pt;line-height:100%;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">C.</font><font style="display: inline;font-size:10pt;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 30pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.&nbsp;&nbsp;In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;line-height:100%;margin-bottom:0pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:100.00%;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">SIGNATURES</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:100.00%;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">SIGNATURES</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:100.00%;padding:0pt 6.5pt">
					<p style="margin:10pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the </font><font style="display: inline;color:#000000;font-size:10pt;background-color: #FFFFFF;">City of Burlingame, California</font><font style="display: inline;font-size:10pt;">, on the </font><font style="display: inline;font-size:10pt;">23rd</font><font style="display: inline;font-size:10pt;"> day of&nbsp;March,&nbsp;2017.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:100.00%;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&#xFEFF;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;line-height:100%;margin-bottom:0pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:09.68%;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:46.36%;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:06.04%;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:37.92%;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:09.68%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:46.36%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:06.04%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:37.92%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:09.68%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt 0pt 12pt;text-indent: -12pt;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:46.36%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt 0pt 12pt;text-indent: -12pt;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:43.96%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt 0pt 12pt;text-indent: -12pt;font-family:Times New Roman;line-height:107.92%;overflow: hidden;">
						&nbsp;</p>
					<p style="margin:0pt 0pt 5pt 12pt;text-indent: -12pt;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">PULSE BIOSCIENCES, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:09.68%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:46.36%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:06.04%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:37.92%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:09.68%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt 5pt 12pt;text-indent: -12pt;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:46.36%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt 5pt 12pt;text-indent: -12pt;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:06.04%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:5pt 0pt 5pt 12pt;text-indent: -12pt;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">By:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:37.92%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/ Darrin R. Uecker</font></p>
					<p style="margin:1pt 0pt 0pt;border-top:1pt solid #000000 ;line-height:1pt;text-align:center;font-family:Times New Roman;overflow: hidden;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:09.68%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:46.36%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:06.04%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:37.92%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Darrin R. Uecker,</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:09.68%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:46.36%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:06.04%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman;line-height:107.92%;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:37.92%;height:12.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">President and Chief Executive Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:right;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;line-height:100%;margin-bottom:0pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:100.00%;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">POWER OF ATTORNEY</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:100.00%;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">POWER OF ATTORNEY</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:100.00%;padding:0pt 6.9pt;">
					<p style="margin:10pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Each person whose signature appears below hereby constitutes and appoints Darrin R. Uecker and Brian B. Dow, and each of them, as his true and lawful attorney-in-fact and agent with full power of substitution, for him in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8 (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact, proxy and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all</font><font style="display: inline;font-size:10pt;"> intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, proxy and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:100.00%;padding:0pt 6.9pt;">
					<p style="margin:10pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 7pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td colspan="2" valign="middle" style="width:47.38%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="middle" style="width:35.96%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:16.38%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:37.06%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;text-decoration:underline;">Signature</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;text-decoration:underline;">Title</font></p>
				</td>
				<td colspan="3" valign="top" style="width:18.10%;padding:0pt;">
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;text-decoration:underline;">Date</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:37.06%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-weight:bold;font-size:9pt;text-decoration:underline;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="top" style="width:18.10%;padding:0pt;">
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:37.06%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/ Darrin R. Uecker&nbsp;&nbsp;</font></p>
					<p style="margin:1pt 0pt 0pt;border-top:1pt solid #000000 ;line-height:1pt;text-align:center;font-family:Times New Roman;font-size: 4pt">
						<font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;background-color: #FFFFFF;">Darrin R. Uecker</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">President, Chief Executive Officer and Director</font></p>
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-style:italic;font-size:10pt;">(Principal Executive Officer)</font></p>
				</td>
				<td colspan="3" valign="top" style="width:18.10%;padding:0pt;">
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">March </font><font style="display: inline;font-size:10pt;">23</font><font style="display: inline;font-size:10pt;">, 2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:37.06%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="middle" style="width:18.10%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:37.06%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/ Brian B. Dow&nbsp;&nbsp;&nbsp;</font></p>
					<p style="margin:1pt 0pt 0pt;border-top:1pt solid #000000 ;line-height:1pt;text-align:center;font-family:Times New Roman;font-size: 4pt">
						<font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 0.75pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;background-color: #FFFFFF;">Brian B. Dow</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;padding:0pt;">
					<p style="margin:0pt;background-color: #FFFFFF;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;">Chief Financial Officer, SVP Administration and Finance,&nbsp;Secretary&nbsp;&amp;&nbsp;Treasurer</font></p>
					<p style="margin:0pt 0pt 1pt;background-color: #FFFFFF;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-style:italic;color:#000000;font-size:10pt;">(Principal Financial and Accounting Officer</font><font style="display: inline;font-size:10pt;">)</font></p>
				</td>
				<td colspan="3" valign="top" style="width:18.10%;padding:0pt;">
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">March </font><font style="display: inline;font-size:10pt;">23</font><font style="display: inline;font-size:10pt;">, 2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:37.06%;height:13.95pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;height:13.95pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="middle" style="width:18.10%;height:13.95pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:37.06%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/ Robert M. Levande</font></p>
					<p style="margin:1pt 0pt 0pt;border-top:1pt solid #000000 ;line-height:1pt;text-align:center;font-family:Times New Roman;font-size: 4pt">
						<font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;background-color: #FFFFFF;">Robert M. Levande</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Director</font></p>
				</td>
				<td colspan="3" valign="top" style="width:18.10%;padding:0pt;">
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">March </font><font style="display: inline;font-size:10pt;">23,</font><font style="display: inline;font-size:10pt;"> 2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:37.06%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="middle" style="width:18.10%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:37.06%;height:25.65pt;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&nbsp;/s/ Robert Greenberg, M.D.&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
					<p style="margin:1pt 0pt 0pt;border-top:1pt solid #000000 ;line-height:1pt;text-align:center;font-family:Times New Roman;overflow: hidden;">
						<font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 0.75pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;background-color: #FFFFFF;">Robert Greenberg, M.D.</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;height:25.65pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Director</font></p>
				</td>
				<td colspan="3" valign="top" style="width:18.10%;height:25.65pt;padding:0pt;">
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">March </font><font style="display: inline;font-size:10pt;">23</font><font style="display: inline;font-size:10pt;">, 2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:37.06%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="middle" style="width:18.10%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:37.06%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/ Thierry Thaure</font></p>
					<p style="margin:1pt 0pt 0pt;border-top:1pt solid #000000 ;line-height:1pt;text-align:center;font-family:Times New Roman;font-size: 4pt">
						<font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 0.75pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;background-color: #FFFFFF;">Thierry Thaure</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Director</font></p>
				</td>
				<td colspan="3" valign="top" style="width:18.10%;padding:0pt;">
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">March </font><font style="display: inline;font-size:10pt;">23</font><font style="display: inline;font-size:10pt;">, 2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:37.06%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="middle" style="width:18.10%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:37.06%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/ Mitchell Levinson</font></p>
					<p style="margin:1pt 0pt 0pt;border-top:1pt solid #000000 ;line-height:1pt;text-align:center;font-family:Times New Roman;font-size: 4pt">
						<font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 0.75pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;background-color: #FFFFFF;">Mitchell Levinson</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Director</font></p>
				</td>
				<td colspan="3" valign="top" style="width:18.10%;padding:0pt;">
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">March </font><font style="display: inline;font-size:10pt;">23</font><font style="display: inline;font-size:10pt;">, 2017</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="middle" style="width:47.38%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:35.96%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:16.38%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:37.06%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">/s/ Mahkam Zanganeh</font></p>
					<p style="margin:1pt 0pt 0pt;border-top:1pt solid #000000 ;line-height:1pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;">&nbsp;</font></p>
					<p style="margin:0pt 0pt 0.75pt 12pt;line-height:100%;text-indent: -12pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;color:#000000;font-size:10pt;background-color: #FFFFFF;">Mahkam </font><font style="display: inline;color:#000000;font-size:10pt;">Zanganeh</font></p>
				</td>
				<td colspan="2" valign="top" style="width:44.82%;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Director</font></p>
				</td>
				<td colspan="3" valign="top" style="width:18.10%;padding:0pt;">
					<p style="margin:0pt 0pt 0.75pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">March </font><font style="display: inline;font-size:10pt;">23</font><font style="display: inline;font-size:10pt;">, 2017</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="2" valign="middle" style="width:47.38%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:35.96%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="middle" style="width:16.38%;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 1pt">
			<font style="display: inline;font-size:1pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 11pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 10pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:center;font-weight:bold;font-family:Times New Roman;;font-size: 10pt"><font style="display: inline;font-size:10pt;">EXHIBIT INDEX</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:09.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:45.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:07.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:14.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:10.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:13.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.9pt;">
					<p style="margin:0pt;font-family:Times New Roman;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:09.48%;background-color: #FFFFFF;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;color:#FFFFFF;font-size:10pt;">&#xFEFF;</font></p>
				</td>
				<td valign="bottom" style="width:45.02%;background-color: #FFFFFF;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td colspan="4" valign="top" style="width:45.50%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">Incorporated by Reference</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:09.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">Exhibit</font><br /><font style="display: inline;font-weight:bold;font-size:10pt;">Number</font></p>
				</td>
				<td valign="bottom" style="width:45.02%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">Description</font></p>
				</td>
				<td valign="bottom" style="width:07.30%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">Form</font></p>
				</td>
				<td valign="bottom" style="width:14.38%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">File No.</font></p>
				</td>
				<td valign="bottom" style="width:10.34%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">Exhibit</font></p>
				</td>
				<td valign="bottom" style="width:13.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 3pt;border-bottom:1pt solid #000000 ;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-weight:bold;font-size:10pt;">Filing Date</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">4.1</font></p>
				</td>
				<td valign="top" style="width:45.02%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Form of Common Stock certificate of the Registrant</font></p>
				</td>
				<td valign="top" style="width:07.30%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">S-1/A</font></p>
				</td>
				<td valign="top" style="width:14.38%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">333-208694</font></p>
				</td>
				<td valign="top" style="width:10.34%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">4.1</font></p>
				</td>
				<td valign="top" style="width:13.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">03/07/2016</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">4.2</font></p>
				</td>
				<td valign="top" style="width:45.02%;padding:0pt 6.9pt;">
					<p style="margin:5pt 0pt 4pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">2015 Stock Incentive Plan</font></p>
				</td>
				<td valign="top" style="width:07.30%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">S-1</font></p>
				</td>
				<td valign="top" style="width:14.38%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">333-208694</font></p>
				</td>
				<td valign="top" style="width:10.34%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">10.2</font></p>
				</td>
				<td valign="top" style="width:13.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">12/22/2015</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">4.3</font></p>
				</td>
				<td valign="top" style="width:45.02%;padding:0pt 6.9pt;">
					<p style="margin:5pt 0pt 4pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Form of Pulse Biosciences, Inc. Stock Option Agreement (used for Robert M. Levande, Mitchell E. Levinson, Robert J. Greenberg, and Thierry Thaure)</font></p>
				</td>
				<td valign="top" style="width:07.30%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">S-1</font></p>
				</td>
				<td valign="top" style="width:14.38%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">333-208694</font></p>
				</td>
				<td valign="top" style="width:10.34%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">10.3</font></p>
				</td>
				<td valign="top" style="width:13.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">12/22/2015</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">5.1</font></p>
				</td>
				<td valign="top" style="width:45.02%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Opinion of Fennemore Craig, P.C.</font></p>
				</td>
				<td valign="top" style="width:07.30%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:14.38%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:10.34%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:13.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">23.1</font></p>
				</td>
				<td valign="top" style="width:45.02%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Consent of Gumbiner Savett Inc., Independent Registered Public Accounting Firm</font></p>
				</td>
				<td valign="top" style="width:07.30%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:14.38%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:10.34%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:13.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">23.2</font></p>
				</td>
				<td valign="top" style="width:45.02%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Consent of Fennemore Craig, P.C. (included in Exhibit&nbsp;5.1)</font></p>
				</td>
				<td valign="top" style="width:07.30%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:14.38%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:10.34%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:13.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;line-height:107.92%;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">24.1</font></p>
				</td>
				<td valign="top" style="width:45.02%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;">Power of Attorney (contained on signature pages hereto)</font></p>
				</td>
				<td valign="top" style="width:07.30%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:14.38%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:10.34%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:13.48%;padding:0pt 6.9pt;">
					<p style="margin:0pt 0pt 4pt;line-height:100%;text-align:center;font-family:Times New Roman;font-size: 11pt">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:center;font-weight:bold;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-weight:normal;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "plse-20170323xs8.htm", "description": "S-8", "secsgml_size_bytes": 131472}]
{"company-data": {"conformed-name": "Pulse Biosciences, Inc.", "cik": "0001625101", "assigned-sic": "3841", "irs-number": "465696597", "state-of-incorporation": "NV", "fiscal-year-end": "1217"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-216897", "film-number": "17709418"}, "business-address": {"street1": "849 MITTEN ROAD", "street2": "SUITE 104", "city": "BURLINGAME", "state": "CA", "zip": "94010", "phone": "650-697-3939"}, "mail-address": {"street1": "849 MITTEN ROAD", "street2": "SUITE 104", "city": "BURLINGAME", "state": "CA", "zip": "94010"}, "former-company": {"former-conformed-name": "Electroblate, Inc.", "date-changed": "20141113"}}
S-8 2017-03-22
﻿
﻿
As filed with the Securities and Exchange Commission on March 2
3
, 2017
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Pulse Biosciences, Inc.
(Exact name of Registrant as specified in its charter)
﻿
Nevada
46-5696597
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
849 Mitten Road, Suite 104
Burlingame, CA 94010
(Address of principal executive offices, including zip code)
2015 Stock Incentive Plan
Pulse Biosciences, Inc. Stock Option Agreement dated February 1, 2015
between Pulse Biosciences, Inc. and Robert M. Levande
Pulse Biosciences, Inc. Stock Option Agreement dated February 1, 2015
between Pulse Biosciences, Inc. and Mitchell E. Levinson
Pulse Biosciences, Inc. Stock Option Agreement dated June 1, 2015
between Pulse Biosciences, Inc. and Robert J. Greenberg
Pulse Biosciences, Inc. Stock Option Agreement dated June 16, 2015
between Pulse Biosciences, Inc. and Thierry Thaure
(Full title of the plan)
Darrin R. Uecker
Chief Executive Officer
Pulse Biosciences, Inc.
849 Mitten Road, Suite 104
Burlingame, CA 94010
(650) 697-3939
(Name, address and telephone number, including area code, of agent for service)
Andrew D. Hoffman
Wilson Sonsini Goodrich & Rosati, P.C.
650 Page Mill Road
Palo Alto, California 94304
(650) 493-9300
Copies to:
Brian B. Dow
Chief Financial Officer
Pulse Biosciences, Inc.
849 Mitten Road, Suite 104
Burlingame, CA 94010
(650) 697-3939
﻿
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act (Check one).
Large accelerated filer
☐
Non-accelerated filer
☐
(Do not check if a smaller reporting company)
Accelerated filer
Smaller reporting company
☐
☒
﻿
﻿
﻿
﻿
CALCULATION OF REGISTRATION FEE
Title of Securities to be Registered
Amount
to be Registered (1)
Proposed
Maximum Offering
Price Per Share
Proposed
Maximum Aggregate Offering Price
Amount of
Registration Fee
Common Stock, $0.001 par value per share:
—Reserved for issuance under the 2015 Stock Incentive Plan
208,248 (2)
$23.57 (4)
$4,908,405.36
$568.89
—Reserved for issuance pursuant to
equity awards outstanding under the 2015 Stock Incentive Plan
922,970 (3)
$4.19 (5)
$3,867,244.30
$448.22
—Reserved for issuance pursuant to
the Pulse Biosciences, Inc. Stock Option Agreement dated February 1, 2015 between Pulse Biosciences, Inc. and Robert M. Levande
75,655
$2.67 (6)
$201,998.85
$23.42
—Reserved for issuance pursuant to
the Pulse Biosciences, Inc. Stock Option Agreement dated February 1, 2015 between Pulse Biosciences, Inc. and Mitchell E. Levinson
75,655
$2.67 (6)
$201,998.85
$23.42
—Reserved for issuance pursuant to
the Pulse Biosciences, Inc. Stock Option Agreement dated June 1, 2015 between Pulse Biosciences, Inc. and Robert J. Greenberg
75,655
$2.67 (6)
$201,998.85
$23.42
—Reserved for issuance pursuant to
the Pulse Biosciences, Inc. Stock Option Agreement dated June 16, 2015 between Pulse Biosciences, Inc. and Thierry Thaure
75,655
$2.67 (6)
$201,998.85
$23.42
Total:
1,433,838
$9,583,645.06
$1,110.79
﻿
(1)
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of common stock of the Registrant that become issuable under the 2015 Stock Incentive Plan (the "2015 Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant's outstanding shares of common stock.
(2)
Represents
208,248
shares of common stock reserved for issuance pursuant to future awards under the 2015 Plan as of the date of the Registration Statement.
(3)
Represents 922,970 shares of common stock subject to outstanding awards previously granted under the
2015 Plan
as of the date of this Registration Statement.
(4)
Estimated solely for the purposes of determining the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act of 1933, as amended, on the basis of $23.57, which represents the average of the high and low prices of the Registrant's Common Stock, as reported on the
Nasdaq
Capital Market on March 20, 2017.
(5)
Estimated solely for the purposes of determining the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act of 1933, as amended, on the basis of $
4.19
, the weighted-average exercise price for outstanding option awards granted under the 2015 Plan as of the date of the Registration Statement.
(6)
Estimated solely for the purposes of determining the registration fee pursuant to Rule 457(h) under the Securities Act of 1933, as amended, on the basis of $2.67, the exercise price for outstanding option awards granted under the applicable Stock Option Agreement.
﻿
PART I
INFORMATION REQUIRED IN THE PROSPECTUS
The information specified in Item 1 and Item 2 of Part I of Form S-8 is omitted from this Registration Statement on Form S-8 (the "
Registration Statement
") in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the "
Securities Act
"), and the introductory note to Part I of Form S-8.  The documents containing the information specified in Part I of Form S-8 will be delivered to the participants of the equity benefit plans and to option award recipients pursuant to stock option agreements covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.  Incorporation of Documents by Reference.
﻿
Pulse Biosciences, Inc. (the "
Registrant
") hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the "
Commission
"):
(1)
The Registrant's Annual Report on Form 10-K for its fiscal year ended December 31, 2016, filed with the Commission on March 20, 2017;
﻿
(2)
All other reports filed by the Registrant with the Commission pursuant to Sections 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Registrant's Annual Report referred to in (1) above; and
(3)
The description of the Registrant's Common Stock contained in the Registrant's Registration Statement on Form 8-A (File No. 001-37744) filed with the Commission on April 15, 2016
pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the "
Exchange Act
"), including any amendment or report filed for the purpose of updating such description.
﻿
All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the respective dates of filing of such documents;
provided
,
however
, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement.
﻿
Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.  Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
﻿
Item 4.  Description of Securities.
﻿
Not applicable.
﻿
Item 5.  Interests of Named Experts and Counsel.
﻿
Not applicable.
﻿
Item 6.  Indemnification of Directors and Officers.
﻿
Under Sections 78.7502, 78.751 and 78.752 of the Nevada Revised Statutes, the Registrant has broad powers to indemnify and insure its directors and officers against liabilities they may incur in their capacities as such.
The Registrant's officers and directors are shielded, as provided by the Nevada Revised Statutes and the Registrant's articles of incorporation and bylaws, from liability to the company or the stockholders for monetary liabilities unless it is specifically
limited by its articles of incorporation.  The Registrant's articles of incorporation do not impose any limit on its directors' liability.  Excepted under the law from that limitation of liability are: (a) a willful failure to deal fairly with the company or its stockholders in connection with a matter in which the director has a material conflict of interest; (b) a violation of criminal law, unless the director had reasonable cause to believe that his or her conduct was lawful or no reasonable cause to believe that his or her conduct was unlawful; (c) a transaction from which the director derived an improper personal profit; and (d) willful misconduct.
The Registrant's articles of incorporation and bylaws provide that it will indemnify its directors and officers to the fullest extent not prohibited by Nevada law; provided, however, that it may modify the extent of such indemnification by individual contracts with its directors and officers; and, provided, further, that it shall not be required to indemnify any director or officer in connection with any proceeding, or part thereof, initiated by such person unless such indemnification: (a) is expressly required to be made by law, (b) the proceeding was authorized by the Registrant's board of directors, (c) is provided by it, in its sole discretion, pursuant to the powers vested in it under Nevada law or (d) is required to be made pursuant to the bylaws.
In addition to the foregoing, the Registrant has entered into individual indemnification agreements with each of its directors, which provide for the indemnification of each of them for any expenses, settlements and other costs associated or incurred with their defense or involvement with an action brought by a stockholder or third party in connection with their activities as a director.  The Registrant maintains insurance coverage for the benefit of its current and past directors, officers and employees, including those of its subsidiaries.
These indemnification provisions and the indemnification agreements entered into between the Registrant and its officers and directors may be sufficiently broad to permit indemnification of the Registrant's officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act.
See also the undertakings set out in response to Item 9 herein.
Item 7.  Exemption from Registration Claimed.
Not applicable.
Item 8.  Exhibits.
See the Exhibit Index on the page immediately following the signature pages to the Registration Statement.
Item 9. Undertakings.
A.
The undersigned Registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)
To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective Registration Statement; and
(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.
Provided, however
, that paragraphs (A)(1)(i) and (A)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission
by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.
(2)
That, f
or the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
B.
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
C.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
﻿
SIGNATURES
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the
City of Burlingame, California
, on the
23rd
day of March, 2017.
﻿
﻿
﻿
﻿
﻿
﻿
PULSE BIOSCIENCES, INC.
﻿
﻿
By:
/s/ Darrin R. Uecker
﻿
Darrin R. Uecker,
﻿
President and Chief Executive Officer
﻿
POWER OF ATTORNEY
POWER OF ATTORNEY
Each person whose signature appears below hereby constitutes and appoints Darrin R. Uecker and Brian B. Dow, and each of them, as his true and lawful attorney-in-fact and agent with full power of substitution, for him in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8 (including post-effective amendments), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact, proxy and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all
intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, proxy and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.
﻿
Signature
Title
Date
﻿
/s/ Darrin R. Uecker
Darrin R. Uecker
President, Chief Executive Officer and Director
(Principal Executive Officer)
March
23
, 2017
﻿
/s/ Brian B. Dow
Brian B. Dow
Chief Financial Officer, SVP Administration and Finance, Secretary & Treasurer
(Principal Financial and Accounting Officer
)
March
23
, 2017
﻿
/s/ Robert M. Levande
Robert M. Levande
Director
March
23,
2017
﻿
/s/ Robert Greenberg, M.D.
Robert Greenberg, M.D.
Director
March
23
, 2017
﻿
/s/ Thierry Thaure
Thierry Thaure
Director
March
23
, 2017
﻿
/s/ Mitchell Levinson
Mitchell Levinson
Director
March
23
, 2017
﻿
/s/ Mahkam Zanganeh
Mahkam
Zanganeh
Director
March
23
, 2017
﻿
﻿
EXHIBIT INDEX
﻿
﻿
﻿
﻿
Incorporated by Reference
Exhibit
Number
Description
Form
File No.
Exhibit
Filing Date
4.1
Form of Common Stock certificate of the Registrant
S-1/A
333-208694
4.1
03/07/2016
4.2
2015 Stock Incentive Plan
S-1
333-208694
10.2
12/22/2015
4.3
Form of Pulse Biosciences, Inc. Stock Option Agreement (used for Robert M. Levande, Mitchell E. Levinson, Robert J. Greenberg, and Thierry Thaure)
S-1
333-208694
10.3
12/22/2015
5.1
Opinion of Fennemore Craig, P.C.
23.1
Consent of Gumbiner Savett Inc., Independent Registered Public Accounting Firm
23.2
Consent of Fennemore Craig, P.C. (included in Exhibit 5.1)
24.1
Power of Attorney (contained on signature pages hereto)
﻿